Skip to content

Default mode network: all studies

Page 73 of 155: studies 721 to 730 of 1,549, newest first. Back to the default mode network overview

Research

Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.

ACS Chemical Neuroscience May 7, 2025 Hongshuang Wang, Xiaohui Wang 5 citations

This viewpoint explores the therapeutic potential of psychedelics in treating neuropsychiatric disorders, particularly through the modulation of brain entropy and the experience of ego dissolution. Psychedelics disrupt rigid neural patterns, facilitating enhanced connectivity and fostering profound emotional breakthroughs that may alleviate symptoms of disorders like depression, anxiety, PTSD,...

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Imaging Neuroscience April 16, 2025 Lorenzo Pasquini, Alexander J. Simon, Courtney L. Gallen et al. 4 citations

Abstract N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, characterized by a profound and immersive sense of physical transcendence alongside rich and vivid auditory distortions and visual imagery. Multimodal neuroimaging data paired with dynamic analysis techniques offer a valuable approach for identifying...

Schrödinger's cat and mouse: An adapted thought experiment for the context of consciousness.

Behavioural Brain Research April 12, 2025 Eamonn Eeles, Dana Pourzinal, Jalal Baland et al.

Consciousness, at its simplest, represents awareness of self in relation to the outside world. This can be divided further into the reasoning and rationality of Access consciousness (A-C) versus the experiential and 'what it's like' of Phenomenal consciousness (P-C). A-C is directly measurable, using standard tests of cognition and memory. However, owing to the subjective nature of P-C, its...

Enhancing Equanimity With Noninvasive Brain Stimulation: A Novel Framework for Mindfulness Interventions.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging April 1, 2025 Brian Lord, John J B Allen, Shinzen Young et al. 4 citations

Mindfulness has gained widespread recognition for its benefits for mental health, cognitive performance, and well-being. However, the multifaceted nature of mindfulness, which encompasses elements such as attentional focus, emotional regulation, and present-moment awareness, complicates its definition and measurement. A key component that may underlie its broad benefits is equanimity-the...

Dynamical repertoire of brain networks in mindfulness cognitive behavioural therapy during rumination: A randomized controlled trial

medRxiv February 7, 2025 Jakub Vohryzek, Anne Maj van der Velden, Willem Kuyken et al. 1 citation preprint

BACKGROUND: Depression is a prevalent and debilitating affective disorder characterised by the dominance and persistence of depressive rumination. Mindfulness-based cognitive therapy (MBCT) is an effective treatment for recurrent depression developed specifically to target rumination and recurrence risk by training metacognitive awareness and adaptive attention, emotion and self-regulation...

Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review

Journal of Psychopharmacology January 20, 2025 Joshua Liebnau, Felix Betzler, André Kerber 10 citations

Background: Recent clinical trials suggest promising antidepressant effects of psilocybin, despite methodological challenges. While various studies have investigated distinct mechanisms and proposed theoretical opinions, a comprehensive understanding of psilocybin’s neurobiological and psychological antidepressant mechanisms is lacking. Aims: Systematically review potential antidepressant...

Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications

Pharmaceuticals January 19, 2025 Marco Bonaso, Letizia Biso, Benedetta Zucchini et al. 13 citations

Psychedelics, historically celebrated for their cultural and spiritual significance, have emerged as potential breakthrough therapeutic agents due to their profound effects on consciousness, emotional processing, mood, and neural plasticity. This review explores the mechanisms underlying psychedelics’ effects, focusing on their ability to modulate brain connectivity and neural circuit activity,...

Mindfulness and MBCT-vision (mindfulness-based cognitive therapy modified for visual symptoms) for visual snow syndrome: a therapeutic perspective.

Frontiers in Neurology 2025 Sui H Wong, Janet Wingrove 1 citation

Visual snow syndrome (VSS) is a neurological disorder characterized by intrusive visual symptoms and associated with dysregulation in brain networks, including the Salience Network, Default Mode Network, and thalamocortical circuits. This perspective paper examines the application of mindfulness-based cognitive therapy modified for visual symptoms (MBCT-vision) as an intervention for VSS....

DOI: 10.3389/fneur.2025.1596642 (opens in new tab) Full text (opens in new tab) Default mode network Attention network Lifestyle intervention Mindfulness-based intervention +2

Dynamical structure-function correlations provide robust and generalizable signatures of consciousness in humans

Communications Biology September 30, 2024 Pablo Castro, Andrea I. Luppi, Enzo Tagliazucchi et al. 21 citations

Resting-state functional magnetic resonance imaging evolves through a repertoire of functional connectivity patterns which might reflect ongoing cognition, as well as the contents of conscious awareness. We investigated whether the dynamic exploration of these states can provide robust and generalizable markers for the state of consciousness in human participants, across loss of consciousness...

DOI: 10.1038/s42003-024-06858-3 (opens in new tab) Default mode network Unconsciousness Dynamic functional connectivity Cognition +7

Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder

Psychedelics September 24, 2024 Xi Zhu, Chen Zhang, David J Hellerstein et al. 6 citations

Body dysmorphic disorder (BDD) is a severe psychiatric condition characterized by preoccupation with perceived flaws in one's appearance, which the individual views as defective or ugly. Psilocybin, a serotonin 2A receptor agonist with psychedelic properties, has emerged as a potential therapeutic agent for depression and other psychiatric disorders. This study aimed to identify subacute neural...